Organoid-guided vs Topotecan Therapy in Relapsed Extensive-Stage Small Cell Lung Cancer

NCT07106528 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

128

Enrollment

OTHER

Sponsor class

Conditions

Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Extensive-stage Small Cell Lung Cancer (SCLC)
Small Cell Lung Cancer ( SCLC )

Interventions

DRUG: Organoid Drug Sensitivity Testing-Guided Therapy
DRUG: Topotecan

Sponsor

Peking Union Medical College Hospital